Notice of dividend

RNS Number : 8740R

The MedicX Fund Limited

31 October 2013

 



Press Release

For immediate release                                                                                    

31 October 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of dividend

The Directors have approved a quarterly dividend of 1.425p per ordinary share in respect of the period 1 July 2013 to 30 September 2013.  This will bring the total dividends declared in respect of the financial year ended 30 September 2013 to 5.7p per Ordinary Share, an increase from the dividends of 5.6p declared for the year ended 30 September 2012.  The dividend will be paid on 31 December 2013 to ordinary shareholders on the register as at 15 November 2013 (the "Record Date").  The corresponding ex-dividend date will be 13 November 2013.

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 31 December 2013, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010.

The option to participate will be available to shareholders until 6 December 2013 (the "election date").  Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through the Scrip Dividend portal on the Company's website http://www.medicxfund.com/scrip).

End

For further information please contact:

MedicX Group                                                                 [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity Limited                                               [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan                                                                       [phone]

Charles Ryland/Sophie McNulty

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 122 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCFMMFGMMLGFZM